×

Method for treatment of diseases

  • US 9,987,292 B2
  • Filed: 12/02/2015
  • Issued: 06/05/2018
  • Est. Priority Date: 06/22/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method of reducing symptoms, duration and/or severity of vasogenic cerebral edema in a human comprising orally administering to the human a vascular-hyperpermeability-inhibiting amount of danazol or pharmaceutically-acceptable salts of danazol, wherein the hyperpermeability-inhibiting amount is from 1 mg to 100 mg per day.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×